[1]
Batra, A. et al. 2019. Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline. Canadian Urological Association Journal. 14, 2 (Jul. 2019), 43–7. DOI:https://doi.org/10.5489/cuaj.5802.